Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

AUTOLOGOUS AND HOMOLOGOUS TRANSFUSION OF HUMAN ASCITIC FLUID
H. A. Davis, J. F. Blalock Jr.
H. A. Davis, J. F. Blalock Jr.
Published March 1, 1939
Citation Information: J Clin Invest. 1939;18(2):219-224. https://doi.org/10.1172/JCI101037.
View: Text | PDF
Research Article

AUTOLOGOUS AND HOMOLOGOUS TRANSFUSION OF HUMAN ASCITIC FLUID

  • Text
  • PDF
Abstract

Authors

H. A. Davis, J. F. Blalock Jr.

×

Total citations by year

Year: 2021 2017 2013 1988 1984 1966 1961 1960 1942 1941 1939 Total
Citations: 3 1 1 2 1 1 1 1 1 1 1 14
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (14)

Title and authors Publication Year
Quality of life assessment of cell‐free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study
K Yamamoto, S Nagao, T Tsu, T Matsushima, Y Ishido, M Narita, K Suzuki, H Nakazawa, T Shibutani, T Jimi, H Yano, M Kitai, T Shiozaki, K Matsuoka, S Yamaguchi
The journal of obstetrics and gynaecology research 2021
Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study
K Ishitani, A Isoai, T Ito, H Sugiyama, A Arakawa, Y Yamada, H Onodera, R Kobayashi, N Torii, N Soneda, Y Matsuno, T Utsugisawa, M Kato, N Hanafusa
International Journal of Clinical Oncology 2021
Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study.
Ishitani K, Isoai A, Ito T, Sugiyama H, Arakawa A, Yamada Y, Onodera H, Kobayashi R, Torii N, Soneda N, Matsuno Y, Utsugisawa T, Kato M, Hanafusa N
International Journal of Clinical Oncology 2021
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results
N Hanafusa, A Isoai, T Ishihara, T Inoue, K Ishitani, T Utsugisawa, T Yamaka, T Ito, H Sugiyama, A Arakawa, Y Yamada, Y Itano, H Onodera, R Kobayashi, N Torii, T Numata, T Kashiwabara, Y Matsuno, M Kato, Y Isaka
PloS one 2017
Blood Transfusion
RB Scott
Blood Transfusion 2013
Peritoneovenous shunting for intractable cirrhotic and cancerous ascites using different types of shunting tubes
K Akimaru, Y Ueda, T Shoji
The Japanese Journal of Surgery 1988
Peritoneovenous shunting for intractable cirrhotic and cancerous ascites using different types of shunting tubes.
Akimaru K, Ueda Y, Shoji T
The Japanese Journal of Surgery 1988
Surgical treatment of portal hypertension: A historical perspective
AJ Donovan
World Journal of Surgery 1984
Elective treatment of bleeding esophageal varices
HE Gordon, G Glantz
Current Problems in Surgery 1966
Effects of Ascitic Fluid Infusion on Sodium Excretion, Blood Volume, and Creatinine Clearance in Cirrhosis
HS Yamahiro, TB Reynolds
Gastroenterology 1961
Ergebnisse der Inneren Medizin und Kinderheilkunde
L Heilmeyer, R Schoen, B Rudder
1960
Shock und Kollaps
H Schwiegk
Klinische Wochenschrift 1942
Biochemical aspects of preoperative and postoperative treatment its practical application
R Green
The American Journal of Surgery 1941
Shock
RD Cressman, A Blalock
The American Journal of Surgery 1939

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts